Table 3. Feasibility of S-1.

	Arm A (n=50)	Arm B (n=51)
Cumulative rate of total administration
days of S-1 on 112-day (95% CI)	69.4% (56.0–82.9%)	54.4% (40.6–68.1%)
Total administration days
Mean	87.3 days	87.2 days
Standard deviation	37.3 days	35.7 days
Cumulative rate of the relative total
administration dose of S-1 at 100% (95% CI)	54.9% (40.1–69.7%)	34.3% (21.1–47.4%)
Relative total administration dose
Mean	76.1%	75.7%
Standard deviation	33.2%	31.3%